Browsing: Gene therapy

From 1 August 2024, Singapore’s Ministry of Health has introduced substantial subsidies for high-cost cell, tissue, and gene therapies, providing a lifeline for patients needing advanced treatments such as CAR T-cell therapy. The subsidies are aimed at making these treatments more accessible by adjusting the coverage based on household income and patient needs, with caps of up to $150,000 for citizens and $45,000 for permanent residents

Innovative Gene Therapy for Glioblastoma by NUS Medicine National University of Singapore’s Yong Loo Lin School of Medicine (NUS Medicine)…